These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6552838)

  • 21. [Urinary kallikrein quantity and activity in normal pregnant women in the third trimester].
    Hiruta M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1156-60. PubMed ID: 3849561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An optimized assay for prekallikrein activator activity in human plasma products.
    Tölö H; Suomela H
    Thromb Res; 1982 Jul; 27(1):35-44. PubMed ID: 6981866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reference intervals for plasma sulfate and urinary sulfate excretion in pregnancy.
    Dawson PA; Petersen S; Rodwell R; Johnson P; Gibbons K; McWhinney A; Bowling FG; McIntyre HD
    BMC Pregnancy Childbirth; 2015 Apr; 15():96. PubMed ID: 25885354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contact activation of prekallikrein and of fibrinolysis by heparinoids and heparin.
    Soulier JP; Gozin D
    Haematologia (Budap); 1980; 13(1-4):117-28. PubMed ID: 6166520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible role of prekallikrein in the mechanism of labor.
    Maki M; Soga K
    Tohoku J Exp Med; 1981 Feb; 133(2):139-43. PubMed ID: 6911898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of factor XII and plasma prekallikrein with chromozym PK].
    Stürzebecher J; Klessen C; Markwardt F
    Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1983 Feb; 31(2):219-22. PubMed ID: 6190027
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen.
    Scicli AG; Mindroiu T; Scicli G; Carretero OA
    J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 30. [Micromethod for determining prekallikrein in blood plasma using a chromogenic substrate].
    Kuznetsov VA
    Lab Delo; 1985; (7):400-2. PubMed ID: 2414517
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Description and evaluation of a new chromogenic substrate assay kit for the determination of prekallikrein in human plasma.
    Friberger P; Gallimore MJ
    Adv Exp Med Biol; 1986; 198 Pt B():543-8. PubMed ID: 3643742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombin III and plasminogen: a comparison of two synthetic substrate-based methods.
    Ito RK; Statland BE
    Am J Clin Pathol; 1983 Oct; 80(4):465-73. PubMed ID: 6624709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assay for Hageman factor (factor XII) in human plasma by means of chromogenic substrate for plasma kallikrein.
    Egberg N; Overmark-Berggren I
    Thromb Res; 1983 Sep; 31(6):875-80. PubMed ID: 6557688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on assays for plasma prekallikrein and for the monitoring of coumarol therapy.
    Egberg N; Bergström K
    Haemostasis; 1978; 7(2-3):85-91. PubMed ID: 149049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responses of active and inactive plasma renin and changes in urinary kallikrein and plasma prekallikrein to various conditions in normal subjects.
    Nakamaru M; Ogihara T; Higaki J; Hata T; Ohde H; Naka T; Masuo K; Gotoh S; Kumahara Y; Murakami K
    J Clin Endocrinol Metab; 1982 Apr; 54(4):682-8. PubMed ID: 7037811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K; Kleist R; Hardt J; Witzke G
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma prekallikrein in hypertension.
    Bruhn HD; Brück M; Albert JP
    Acta Chir Scand Suppl; 1982; 509():133-5. PubMed ID: 6962616
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of severity and prognosis in early stages of septicemia by means of chromogenic peptide substrate assays.
    Smith-Erichsen N; Aasen AO
    Eur Surg Res; 1984; 16 Suppl 2():140-6. PubMed ID: 6373297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of the sulfated 3,3'-diiodothyronine radioimmunoassay and its application in pregnant women.
    Huang WS; Roan CS; Kuo SW; Yan JS; Luo JS; Chen WL
    Proc Natl Sci Counc Repub China B; 1995 Oct; 19(4):201-7. PubMed ID: 8742617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.